Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Fresh Tracks Therapeutics (FRTX)
OTHER OTC:FRTX
Holding FRTX?
Track your performance easily
FRTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.55 - $1.03
Previous Close$0.72
Volume221.00
Average Volume (3M)2.32K
Market Cap
$4.27M
Enterprise Value-$6.63M
Total Cash (Recent Filing)$10.90M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.67
Next Earnings
Aug 08, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.41
Shares Outstanding5,973,306
10 Day Avg. Volume1,892
30 Day Avg. Volume2,323
Standard Deviation0.26
R-Squared0.00915
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)0.43
Price to Sales (P/S)0.53
Price to Cash Flow (P/CF)-1.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-0.83
Enterprise Value/Gross Profit-0.83
Enterprise Value/Ebitda1.17
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Fresh Tracks Therapeutics News
PremiumCompany Announcements
Fresh Tracks Therapeutics Ends Deal with Carna Biosciences
PremiumCompany Announcements
Fresh Tracks Therapeutics Shareholders Vote on Dissolution
Ownership Overview
42.00% Insiders
<0.01% Other Institutional Investors
58.00% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
FRTX FAQ
What was Fresh Tracks Therapeutics’s price range in the past 12 months?
Fresh Tracks Therapeutics lowest stock price was $0.55 and its highest was $1.03 in the past 12 months.
What is Fresh Tracks Therapeutics’s market cap?
Currently, no data Available
When is Fresh Tracks Therapeutics’s upcoming earnings report date?
Fresh Tracks Therapeutics’s upcoming earnings report date is Aug 08, 2024 which is 106 days ago.
How were Fresh Tracks Therapeutics’s earnings last quarter?
Currently, no data Available
Is Fresh Tracks Therapeutics overvalued?
According to Wall Street analysts Fresh Tracks Therapeutics’s price is currently Overvalued.
Does Fresh Tracks Therapeutics pay dividends?
Fresh Tracks Therapeutics does not currently pay dividends.
What is Fresh Tracks Therapeutics’s EPS estimate?
Fresh Tracks Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Fresh Tracks Therapeutics have?
Fresh Tracks Therapeutics has 5,973,306 shares outstanding.
What happened to Fresh Tracks Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Fresh Tracks Therapeutics?
Currently, no hedge funds are holding shares in FRTX
---
Company Description
Fresh Tracks Therapeutics
Brickell Biotech, Inc. engages in the development of prescription therapeutics for the treatment of skin diseases. Its pipeline consists of new molecular entities targeting the treatment of the following indications: hyperhidrosis, allergic contact dermatitis, androgenic alopecia, cutaneous t-cell lymphoma and psoriasis. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in 2009 and is headquartered in Boulder, CO.
---
FRTX Earnings Call
Q3 2022
0:00 / 0:00
---
Technical Analysis
---